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The Copenhagen Hip And Groin Outcome Score (HAGOS) was developed to assess dis-
ease-specific consequences in young to middle-aged, physically active hip and/or groin
patients. The study aimed to determine validity and reliability of the Dutch version of the
HAGOS (HAGOS-NL) for middle-aged patients with hip complaints.
Design and methods
To assess validity, 117 participants completed five questionnaires: HAGOS-NL, interna-
tional Hip Outcome Tool (iHOT-12NL), Hip disability and Osteoarthritis Outcome Score
(HOOS), RAND-36 Health Survey and Tegner activity scale. Structural validity was deter-
mined by conducting confirmatory factor analysis. Construct validity was analyzed by for-
mulating predefined hypotheses regarding relationships between the HAGOS-NL and
subscales of the iHOT-12NL, HOOS, RAND-36 and Tegner activity scale. The HAGOS-NL
was filled out again by 67 patients to explore test-retest reliability. Reliability was assessed
in terms of Cronbach’s alpha, Intraclass Correlation Coefficient (ICC), Standard Error of
Measurement (SEM) and Minimal Detectable Change (MDC). The Bland and Altman
method was used to explore absolute agreement.
Results
Factor analysis confirmed that the HAGOS-NL consists of six subscales. All hypotheses
were confirmed, indicating good construct validity. Internal consistency was good, with
Cronbach’s alpha values ranging from 0.89 to 0.98. Test-retest reliability was considered
good, with ICC values of 0.80 and higher. The SEM ranged from 6.6 to 12.3, and MDC at
individual level from 18.3 to 34.1 and at group level from 2.3 to 4.4. Bland and Altman analy-
ses showed no bias.
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Conclusion
The HAGOS-NL is a reliable and valid instrument for measuring pain, physical functioning
and quality of life in middle-aged patients with hip complaints.
Introduction
Musculoskeletal pain is particularly common among the elderly population [1]. A substantial
part of these musculoskeletal complaints is hip and/or groin pain. Approximately 22% of the
Dutch elderly population (ages 65+) experiences hip complaints, with a point prevalence of
17% [2]. However, also people under the age of 65 are affected, with an incidence of approxi-
mately 11% [3].
Hip complaints worsen physical functioning and health-related quality of life [4]. To get an
impression of these disease-specific consequences, including physical functioning and health-
related quality of life, a patient-reported outcome measure (PROM) is often used. Such ques-
tionnaires are already available for elderly patients with hip complaints. It is questionable if
these questionnaires are also suitable for middle-aged hip patients, as physical activity perfor-
mance goals differ from elderly hip patients [5–7].
A disease-specific questionnaire that focuses more on the physical activity performance
goals of younger hip patients was developed by Mohtadi et al. (2012): the international Hip
Outcome Tool 33 (iHOT-33) [8]. The short version of the iHOT-33 is validated and translated
into Dutch: the iHOT-12NL [9]. The iHOT-12NL is a reliable and valid instrument for mea-
suring physical functioning and health-related quality of life in younger patients with hip
pathology [9].
Another questionnaire developed for assessment of disease-specific consequences in youn-
ger to middle-aged patients with hip and/or groin pain is the Copenhagen Hip and Groin
Outcome Score (HAGOS). The HAGOS consists of six subscales: Symptoms, Pain, Physical
function in daily living (ADL), Function in sport and recreation, Participation in physical
activities (PA), and Hip-related quality of life (QOL) [10]. Althoug the HAGOS was originally
developed for young to middle-aged patients with hip and/or groin pain, it is questionable
whether the HAGOS can also be used in a general population of middle-aged patients with hip
complaints, like for example patients with osteoarthritis or hip dysplasia.
The HAGOS is currently available in English, Danish and Swedish [10,11]. Recently, Brans
et al. (2016) translated the HAGOS into Dutch (HAGOS-NL) by forward and backwards
translation and testing of cross-cultural validity. Their study showed that the HAGOS-NL has
sufficient validity and reliability [12]. However, as their study population only consisted of
middle-aged patients who had undergone a groin hernia repair, it needs to be investigated
whether the HAGOS-NL is also valid en reliable in middle-aged patients with hip complaints.
Therefore, the aim of this study was to determine validity and reliability of the HAGOS-NL for
that population.
Methods
Study design and population
In this study the validity and reliability of the HAGOS-NL in patients with hip complaints was
investigated. The study was conducted between January and July 2014 at the orthopedic
departments of University Medical Center Groningen (UMCG) and Martini Hospital Gro-
ningen. The study was reviewed and approved by the Medical Ethical Committee (METC) of
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UMCG (January 21, 2014; no. 2013.514). (Parts) of the study methods have been described in
detail previously [9,13]. Eligible patients were between 18 and 60 years old and were treated
for various pathologies of the hip:
• Hip dysplasia
• Osteoarthritis of the hip treated with conservative treatment, hip arthroscopy or total or par-
tial hip replacement (maximum one and a half year postoperative), including patients who
were on the waiting list
• Avascular necrosis of the femoral head treated with total or partial hip replacement, includ-
ing patients who were on the waiting list
• Traumatic hip fracture treated with total or partial hip replacement
All included participants completed an informed consent form prior to participation.
Measurement procedure
To determine validity of the HAGOS-NL, participants were asked to complete five question-
naires: HAGOS-NL [12], iHOT-12NL [9], HOOS [14,15], RAND-36 [16,17] and the Tegner
activity scale [18]. All questionnaires were sent to the participants by mail, together with an
information letter explaining the procedure and purpose of the study.
To explore test-retest reliability, participants were asked to complete the HAGOS-NL again
after two weeks. This 2-week interval was considered adequate to prevent recall bias and to
ensure that clinical change had not occurred [19]. To detect a possible clinical change in the
interval between the two administrations, patients answered a Global Rating of Change (GRC)
question: “Has there been a change in your hip complaints, compared to two weeks ago?” The
GRC question was answered with a 6-point Likert scale, ranging from “much improved” to
“worse than ever”. Patients who reported being much improved or much deteriorated were
excluded from reliability analyses. Patients who underwent total hip replacement had to be at
least six months postoperative at the time the HAGOS-NL was first administered. At six
months following total hip replacement patients were likely to be in a stable state of recovery
so no change in their physical functioning was expected between the first and second adminis-
tration of the HAGOS-NL.
Questionnaires
HAGOS-NL. The HAGOS is a disease-specific questionnaire for the assessment of symp-
toms, activity limitations, participation restrictions and quality of life in young to middle-aged,
physically active patients with longstanding hip and/or groin pain [10]. A Dutch version of the
HAGOS (HAGOS-NL) is available [12]. The HAGOS-NL consists of six subscales: Symptoms
in hip and/or groin; Pain in hip and/or groin; Function in daily living (ADL); Function in
sport and recreation; Participation in physical activities; and Hip and/or groin-related quality
of life. The questions can be answered using a 5-point Likert scale. For each subscale a sum
score is calculated and converted into a 100-point scale. Higher scores reflect less pain and dis-
ability [10].
iHOT-12NL. The iHOT-12 is a questionnaire that measures physical functioning and
health-related quality of life in younger, physically active patients with hip pathology. A valid
and reliable Dutch version (iHOT-12NL) is available [9]. The iHOT-12NL consists of 12 ques-
tions that are answered by placing a mark on a 100-mm scale, where scores range from 0 to
100, with 100 representing the best possible quality-of-life score. The total score is calculated as
a mean of all responded questions [20].
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HOOS. The HOOS is a questionnaire that assesses the patients’ opinion about their hip
and associated problems. A valid and reliable Dutch version is available [14]. The HOOS con-
sists of five subscales: 1) Pain; 2) Symptoms; 3) Function in daily living (ADL); 4) Function in
sport and recreation; and 5) Hip-related quality of life. Questions are answered using a 5-point
Likert scale. For each subscale, a sum score is calculated which is then converted to a normal-
ized score ranging from 0 to 100, where a lower score reflects more symptoms [14,15].
RAND-36. The RAND-36 is a generic questionnaire that assesses health status and
health-related quality of life. A valid and reliable Dutch version is available [17]. The RAND-
36 includes 36 questions that assess eight health concepts: 1) limitations in physical activities
because of health problems (PF); 2) limitations in social activities because of physical or emo-
tional problems (SF); 3) limitations in usual role activities because of physical health problems
(RP); 4) bodily pain (BP); 5) general mental health (MH); 6) limitations in role activities
because of emotional problems (RE); 7) vitality (VT); and 8) general health perceptions (GH).
For each subscale a sum score is calculated and converted into a 100-point scale. A higher
score indicates better health [16].
Tegner activity scale. The Tegner activity scale is a grading scale where the level of activi-
ties in daily living, recreation and competitive sports can be graded numerically. The patient
chooses one of the 11 levels that best matches his/her level of daily activities. The correspond-
ing level forms the final score, where a higher score indicates a higher level of daily activities.
Patients with Tegner level 4 or higher are defined as physically active [18].
Validity
Structural and construct validity of the HAGOS-NL were assessed. Structural validity is the
degree to which the score of an instrument adequately reflects the dimensionality of the con-
struct being measured. Construct validity is the extent to which scores on a particular instru-
ment relate to other measures, in accordance with predefined hypotheses concerning
measured constructs [19,21]. According to the COSMIN guidelines [21], 14 predefined
hypotheses were formulated about the magnitude of the relationship between the HAGOS-NL
and subscales of the iHOT-12NL, HOOS, RAND-36, and Tegner activity scale (Table 1).
For the relationship between the Swedish versions of the HAGOS and iHOT-12, Thomee et al.
(2014) expected correlations of 0.5 and higher, given that the HAGOS and iHOT-12 are devel-
oped for similar patient groups and essentially measure the same constructs [11]. Based on the
correlations found in the study of Thomee et al. (2014) and Brands et al. (2016), the current study
expected correlations of 0.6 and higher for all subscales of the HAGOS-NL with the iHOT-12NL
[11,12]. As Brans et al. (2016) showed a moderate correlation for the subscale Participation in
physical activities, a smaller correlation of 0.4 and higher was expected for this subscale [12].
Since the HAGOS was developed to measure physical functioning rather than social and/or
emotional aspects, relatively smaller correlations were expected between the HAGOS subscales
and the RAND-36 subscales that tend to measure social and/or emotional aspects. For the sub-
scales of the HAGOS that measure physical functioning, moderate-to-strong correlations were
expected with subscales of the RAND-36 that are also related to physical functioning. These
expectations are in line with those stated in the study of Brans et al. (2016) [12]. Moreover,
as the HAGOS is based on and designed similarly to the HOOS, strong correlations were
expected between the subscales of these questionnaires. Since the HAGOS was originally
designed for physically active patients, these patients (Tegner level4) were expected to score
significantly higher on the HAGOS-NL subscales Function in sport and recreation and Partici-
pation in physical activities than patients with Tegner level<4. Construct validity can be con-
sidered good when at least 75% of the hypotheses are confirmed [19].
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Reliability
Following the COSMIN guidelines [21], reliability was assessed in terms of internal consis-
tency, test-retest reliability and measurement error. Internal consistency refers to the extent to
which subscales of a questionnaire are related; test-retest reliability concerns the extent to
which patients’ scores are the same for repeated measurements; and measurement error is a
measure of systematic error of a patient’s score that is not caused by actual changes in the mea-
sured construct [21]. The Bland and Altman method was used to explore absolute agreement,
which reflects the amount of agreement in repeated measurements [22].
Floor and ceiling effects
To assess the depth of the health measures, floor and ceiling effects were analyzed by calculat-
ing the prevalence of the lowest and highest possible scores [23].
Statistical analysis
A sample size with a minimum of 100 subjects is required for studies on measurement proper-
ties of questionnaires with factor analyses [21], and a sample size of 50 is considered adequate
for determining test-retest reliability [24]. Hence we planned a sample size of at least 100 par-
ticipants to assess construct validity and a sample size of at least 50 to establish test-retest reli-
ability of the HAGOS-NL. All statistical analyses were performed using SPSS version 22.0 for
Windows (SPSS, Armonk, NY, USA). A P-value <0.05 was considered to indicate statistical
significance.
To assess structural validity, principal component confirmatory factor analyses with vari-
max rotation were conducted on all individual subscales. To analyze construct validity,
Table 1. Predefined and confirmed hypotheses.
1 Correlation0.60 between the HAGOS subscales Symptoms, Pain, ADL, Sport and recreation, and
Quality of life and the iHOT-12NL.
2 Correlation0.40 between the HAGOS subscale Participation in physical activities and the iHOT-
12NL.
3 Correlation0.90 between the HAGOS subscales Symptoms and HOOS subscale Symptoms.
4 Correlation0.90 between the HAGOS subscale Pain and HOOS subscale Pain.
5 Correlation0.80 between the HAGOS subscale ADL and HOOS subscale ADL.
6 Correlation0.80 between the HAGOS subscale Function in sport and recreation and HOOS subscale
Function in sport and recreation.
7 Correlation0.90 between the HAGOS subscale Quality of life and HOOS subscale Quality of life.
8 Correlation0.50 between HAGOS subscale Symptoms and RAND-36 subscale Physical functioning,
Role-physical limitations and Bodily pain.
9 Correlation0.60 between HAGOS subscale Pain and RAND-36 subscale Physical functioning and
Bodily pain
10 Correlation0.60 between HAGOS subscale ADL and RAND-36 subscale Physical functioning, Role-
physical limitations and Bodily pain.
11 Correlation0.5 between HAGOS subscale Function in sport and recreation and RAND-36 subscale
Physical functioning, Role-physical limitations and Bodily pain.
12 Correlation0.5 between HAGOS subscale Quality of life and RAND-36 subscale Physical
functioning, Role-physical limitations and Bodily pain.
13 Correlation0.6 between HAGOS subscale Participation in physical activity and RAND-36 subscale
Role-physical limitations.
14 Patients with Tegner level4 score significantly higher on HAGOS-NL subscales Function in sport and
recreation and Participation in physical activities than patients with Tegner level <4.
https://doi.org/10.1371/journal.pone.0186064.t001
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Spearman’s correlation coefficients between the subscales of the HAGOS-NL and (subscales
of) the iHOT-12NL, HOOS, RAND-36 and Tegner activity scale were calculated. Spearman’s
correlations were interpreted according to Domholdt: 0.00 to 0.25 very weak; 0.26 to 0.49
weak; 0.50 to 0.69 moderate; 0.70 to 0.89 strong; and 0.90 to 1.00 very strong [25].
To evaluate whether physically active participants (Tegner level4) have a higher score on
the HAGOS-NL subscales Function in sport and recreation and Participation in physical activi-
ties than participants who are not physically active (Tegner level<4), a Mann-Whitney U-test
was conducted.
Internal consistency was assessed by calculating Cronbach’s alpha for each subscale of the
HAGOS-NL. Values between 0.70 and 0.95 are considered to indicate good internal consis-
tency [19]. To analyze test-retest reliability, Intraclass Correlation Coefficients (ICCs) with
95% Confidence Interval (CI) were calculated for each subscale using a two-way random
effects model, type absolute agreement. According to Terwee et al. (2007), ICC values of 0.70
or higher indicate high test-retest reliability. Measurement error was analyzed by calculating
the Standard Error of Measurement (SEM) and the Minimal Detectable Change (MDC) [19].
SEM was calculated by multiplying the pooled standard deviation by
p
(1-r), where r is the
ICC.[26] From the SEM, the MDC at the individual level (MDCind) was calculated using the
formula 1.96 × SEM ×
p
2 and at the group level by dividing MDCgrp by
p
n [19]. To assess
absolute agreement between the first and second administration of the HAGOS-NL, the
Bland and Altman method was used [22]. The mean difference between the first and second
Fig 1. Flow diagram of inclusion of participants. Abbreviation: GRC, global rating of change.
https://doi.org/10.1371/journal.pone.0186064.g001
Validity and reliability of the HAGOS-NL
PLOS ONE | https://doi.org/10.1371/journal.pone.0186064 October 11, 2017 6 / 16
Table 2. Patient characteristics (N = 117).
Characteristics N (%)
Age (years)* (N = 117) 51 ± 9 (18–60)
Gender (N = 117)
Male 40 (34)
Female 77 (66)
Marital status (N = 117)
Single 23 (20)
With partner 46 (39)
With partner and children 41 (35)
With children 5 (4)
With parents 2 (2)
Educational level (N = 116)
Elementary school 30 (26)
High school 51 (44)
Higher education 34 (29)
Other 1 (1)




Tegner level (N = 117)
Tegner level 0–3 81 (69)
Tegner level 4 26 (22)
Tegner level 5 7 (6)
Tegner level >5 3 (3)
Treatment/indication
Osteoarthritis conservative treatment 7 (6)
Hip arthroscopy 11 (9)
Avascular necrosis 3 (3)
Hip dysplasia 4 (3)
Hip fracture 3 (3)
THA 83 (71)
On waiting list for THA 6 (5)
Comorbidities (N = 117)
Migraine or regular severe headaches 14 (12)
Hypertension 22 (19)
Asthma, chronic bronchitis, pulmonary emphysema or COPD 20 (17)
Severe or persistent indigestion >3 months 4 (3)
Degeneration of the hip or knee joints 80 (68)
Chronic inflammatory arthritis 17 (15)
Severe or persistent back disorders (including hernia) 17 (15)
Diabetes mellitus 10 (9)
Heart attack 1 (1)
Other serious cardiac condition 3 (3)
*Age is reported as mean ± standard deviation (range).
https://doi.org/10.1371/journal.pone.0186064.t002
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administration of all HAGOS-NL subscales with 95% CI were calculated. Zero lying within the
95% CI of the mean difference was considered a criterion for absolute agreement. In addition,
the 95% limits of agreement (LOA) were calculated with the formula mean
difference ± 1.96 × SDdiff, where SDdiff is the standard deviation of the mean difference
between the first and second administration of the HAGOS-NL.
The prevalence of floor and ceiling effects was evaluated. Questionnaires met standards
when the prevalence of floor or ceiling effects was smaller than 15% [23].
Results
Descriptive statistics
For this study, 183 eligible patients were invited to participate (Fig 1); 117 participants (64%)
returned their completed questionnaires. Characteristics of these participants are shown in
Table 2.
Table 3. Structural validity measures of the HAGOS-NL.







Abbreviations: Symptoms, symptoms in hip and/or groin; Pain, pain in hip and/or groin; ADL, function in daily
living; Sport, function in sport and recreation; PA, participation in physical activities; QOL, hip and/or groin-
related quality of life
https://doi.org/10.1371/journal.pone.0186064.t003
Table 4. Spearman’s correlation coefficients between HAGOS-NL subscales and iHOT-12NL, HOOS subscales and RAND-36 subscales.
HAGOS-NL
Symptoms Pain ADL Sport PA QOL
iHOT-12NL 0.87 0.87 0.86 0.84 0.65 0.83
HOOS Symptoms 0.93 0.83 0.81 0.77 0.52 0.80
HOOS Pain 0.90 0.95 0.90 0.85 0.67 0.87
HOOS ADL 0.87 0.91 0.95 0.86 0.65 0.85
HOOS Sport 0.78 0.80 0.82 0.95 0.65 0.80
HOOS QOL 0.81 0.83 0.80 0.81 0.68 0.92
RAND-36 PF 0.73 0.76 0.81 0.79 0.64 0.76
RAND-36 SF 0.58 0.62 0.59 0.58 0.57 0.70
RAND-36 RP 0.62 0.66 0.69 0.56 0.57 0.72
RAND-36 RE 0.26 0.29 0.33 0.27 0.33 0.41
RAND-36 MH 0.38 0.34 0.31 0.28 0.24 0.40
RAND-36 VT 0.54 0.54 0.56 0.56 0.45 0.61
RAND-36 BP 0.74 0.76 0.76 0.71 0.59 0.75
RAND-36 GH 0.38 0.38 0.43 0.35 0.36 0.42
Abbreviations: Symptoms, symptoms in hip and/or groin; Pain, pain in hip and/or groin; ADL, function in daily living; Sport, function in sport and recreation;
PA, participation in physical activities; QOL, hip and/or groin-related quality of life; PF, Physical Functioning; SF, Social Functioning; RP, Role-Physical; RE,
Role-Emotional; MH, Mental Health; VT, Vitality; BP, Bodily Pain; GH, General Health.
https://doi.org/10.1371/journal.pone.0186064.t004
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To evaluate reliability of the HAGOS-NL, 85 participants were invited to fill in the question-
naire for a second time after an interval of two weeks. Thirty-two patients with a total hip replace-
ment were not invited as they were not yet 6 months postoperative at the time of the second
administration. Eventually, 67 questionnaires (79%) were returned. Based on the GRC question,
six participants were excluded from reliability analysis, as one reported that his/her hip com-
plaints were much deteriorated and the other five participants reported that their hip complaints
were much improved. Reliability analysis was therefore conducted with 61 patients (72%).
Validity
Factor analysis for each individual subscale confirmed the structure of six subscales of the
HAGOS. Explained variances ranged from 65 to 90% (Table 3).
Spearman correlations between the HAGOS-NL subscales and the total score of the iHOT-
12NL are shown in Table 4. Moderate-to-high correlations were found, except for the HAGOS-
Table 5. Reliability measures of the HAGOS-NL for each subscale (N = 61).
1st adm. Mean (SD) 2nd adm. Mean (SD) Mean
diff.






Symptoms 56.2 (26.0) 55.4 (23.5) -0.7 -1.8–3.2 0.96 0.92
(0.88–0.95)
6.8 18.9 2.4
Pain 63.0 (26.0) 62.0 (25.4) 1.0 -1.1–3.0 0.98 0.95
(0.92–0.97)
9.1 25.2 3.2
ADL 58.1 (28.3) 58.2 (27.4) -0.1 -2.7–2.5 0.97 0.94
(0.90–0.96)
7.1 19.7 2.5
Sport 42.4 (30.9) 42.0 (29.6) 0.5 -3.1–4.0 0.95 0.90
(0.84–0.94)
9.7 26.8 3.4
PA 39.8 (27.8) 41.0 (27.5) -1.2 -5.7– .2 0.89 0.80
(0.69–0.88)
12.3 34.1 4.4
QOL 46.3 (25.1) 46.6 (23.2) -0.3 -2.7–2.1 0.96 0.93
(0.88–0.96)
6.6 18.3 2.3
Abbreviations: ICC, Intraclass Correlation Coefficient; 95% CI, 95% Confidence Interval; SEM, standard error of measurement; MDCgrp, smallest
detectable change at the group level; MDCind, smallest detectable change at the individual level; Symptoms, symptoms in hip and/or groin; Pain, pain in hip
and/or groin; ADL, function in daily living; Sport, function in sport and recreation; PA, participation in physical activities; QOL, hip and/or groin-related quality
of life.
https://doi.org/10.1371/journal.pone.0186064.t005
Fig 2. Bland and Altman graph of HAGOS subscale Symptoms. Abbreviations: HAGOS, Copenhagen
Hip And Groin Outcome Score; LOA, limits of agreement; 95% CI, 95% confidence interval.
https://doi.org/10.1371/journal.pone.0186064.g002
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NL subscale Participation in physical activities, which correlated weakly. Table 4 also presents
the Spearman correlations between the HAGOS-NL and subscales of the HOOS and RAND-36.
Except for the HAGOS-NL subscale Participation in physical activities, high correlations were
observed with HOOS subscales that measure similar constructs. Similarly, higher correlations
were found between the HAGOS-NL and RAND-36 subscales PF, PR, and BP than between the
HAGOS-NL subscales and RAND-36 subscales MH, VT, RE, SF, and GH.
Comparing scores between patients with low and high activity levels revealed that patients
with high activity levels (Tegner activity level4) scored significantly higher than patients
with lower activity levels (Tegner activity level<4) on the subscales Sport and recreation and
Participation in physical activities of the HAGOS-NL. All predefined hypotheses on the magni-
tude of relationships between the HAGOS-NL and the iHOT-12NL, HOOS, RAND-36, and
Tegner activity scale were confirmed.
Reliability
Results of the reliability analyses are presented in Table 5. Cronbach’s alpha values ranging
from 0.89 to 0.97 indicated good internal consistency. ICC’s ranging from 0.80 to 0.95 were
found. SEM values ranged from 6.6 to 12.3. MDC values at the individual level ranged from
18.3 to 34.1 and at the group level from 2.3 to 4.4. The Bland and Altman analysis showed zero
lying within the 95% CI of the mean difference between the first and second administration of
the HAGOS-NL, ruling out systematic bias (Table 5, Figs 2–7).
Floor and ceiling effects
The frequencies of floor and ceiling effects are presented in Table 6. The prevalence of the min-
imal and maximum scores was lower than 15% [23].
Fig 3. Bland and Altman graph of HAGOS subscale Pain. Abbreviations: HAGOS, Copenhagen Hip And
Groin Outcome Score; LOA, limits of agreement; 95% CI, 95% confidence interval.
https://doi.org/10.1371/journal.pone.0186064.g003
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Discussion
This study aimed to determine validity and reliability of the HAGOS-NL in a general popula-
tion of middle-aged patients with hip complaints. Based on the results, it can be concluded
that the HAGOS-NL is a valid and reliable questionnaire to assess pain, physical functioning
and health-related quality of life in middle-aged patients with hip complaints. Factor analysis
confirmed the structure of six subscales of the original HAGOS, which is in line with the stud-
ies that confirmed this structure for the Dutch, Danish, and Swedish versions of the HAGOS
[10–12].
Construct validity was evaluated by defining 14 hypotheses about the magnitude of the
relationship between the HAGOS-NL and the iHOT-12NL, HOOS and RAND-36. All hypoth-
eses were confirmed, indicating good construct validity. As expected, correlations higher than
0.5 were found between the HAGOS-NL subscales and the total score of the iHOT-12NL.
Although the correlation of the HAGOS-NL subscale Functioning in physical activities with the
iHOT-12NL was higher than in the Swedish validation study [11] (0.65 and 0.37, respectively),
in both studies the comparison yielded the lowest correlation. For the comparisons of the
HAGOS-NL with the HOOS and RAND-36, all hypotheses were confirmed. This pattern was
also confirmed in the other validation studies for the HAGOS [10–12].
Fig 4. Bland and Altman graph of HAGOS subscale ADL. Abbreviations: ADL, Activities of daily living; HAGOS, Copenhagen Hip And
Groin Outcome Score; LOA, limits of agreement; 95% CI, 95% confidence interval.
https://doi.org/10.1371/journal.pone.0186064.g004
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The results also showed that physically active participants had higher scores on the HAGOS-
NL than participants with lower activity levels. This is in line with previous research showing
that physical activity is associated with improvements in various aspects of health-related quality
of life in chronically diseased persons [27]. The HAGOS was originally developed for physically
active patients, but as no floor effects were present it may also be suitable for less physically
active patients. This suggestion is confirmed by sub-analysis in which active and inactive
patients showed similar results.
Internal consistency of the HAGOS-NL proved to be good, with Cronbach’s alpha values rang-
ing from 0.89 to 0.98. These values are comparable with the Dutch, Swedish and Danish validation
studies of the HAGOS [10–12]. However, most subscales have Cronbach’s alpha values exceeding
0.95, which indicates that one or more items in those subscales might be redundant [19,28].
Test-retest reliability of the HAGOS-NL is considered good, with ICC values of 0.80 and
higher. These values are comparable with ICC values found in studies on the validity of other
language versions of the HAGOS [10–12].
The SEM values (6.6 to 12.3) and low MDC values at the group level (2.3 to 4.4) are compa-
rable to SEM and MDC values found by Thorborg et al. (2011), Thomee et al. (2013) and
Brans et al. (2016) [10–12]. Low MDC values at the group level indicate that the HAGOS-NL
Fig 5. Bland and Altman graph of HAGOS subscale Sport. Abbreviations: HAGOS, Copenhagen Hip And Groin Outcome Score; LOA,
limits of agreement; 95% CI, 95% confidence interval.
https://doi.org/10.1371/journal.pone.0186064.g005
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is sufficient for group comparisons, as only low values are needed to detect change. However,
only values higher than the SEM can be distinguished from the measurement error, therefore
to detect a statistically significant change in scores on the HAGOS-NL the difference should be
higher than the SEM. To assess whether the group difference is also clinically important, the
Minimal Important Change (MIC) should be determined [19]. Hence, for evaluative purposes,
the MIC of each HAGOS subscale should be determined in future research.
MDC values at the individual level ranged from 18.3 to 34.1. In order to distinguish from a
measurement error and to confirm a real change occurred, the difference between two mea-
surements should be greater than the MDCind value. It is therefore questionable whether the
HAGOS-NL is an appropriate tool for monitoring health-related quality of life and physical
function in an individual patient over time. This is supported by the studies of Thomee et al.
(2013), Thorborg et al. (2011), and Brans et al. (2016), who showed floor and/or ceiling effects
for the HAGOS [10–12]. However, the current study found that no more than 15% of the
participants achieved the lowest or highest possible score on one of the subscales of the
HAGOS-NL, which supports recommending the HAGOS-NL to detect improvement and
deterioration over time. Differences in findings of floor and ceiling effects may be explained by
differences in patient populations. Future research should consider whether the HAGOS-NL
Fig 6. Bland and Altman graph of HAGOS subscale Functioning in physical activities. Abbreviations: HAGOS, Copenhagen Hip And
Groin Outcome Score; LOA, limits of agreement; 95% CI, 95% confidence interval.
https://doi.org/10.1371/journal.pone.0186064.g006
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is suitable for measuring changes in health status of a patient with hip complaints during a
given time interval.
This study included a relatively high percentage of inactive patients (69%). Because the
HAGOS was initially designed for an active patient group (Tegner score4), floor effects may
Fig 7. Bland and Altman graph of HAGOS subscale Quality of Life. Abbreviations: HAGOS, Copenhagen Hip And Groin Outcome Score;
LOA, limits of agreement; QOL, Quality of life; 95% CI, 95% confidence interval.
https://doi.org/10.1371/journal.pone.0186064.g007
Table 6. Frequency of the minimum and maximum scores on the HAGOS-NL (N = 117).
Mean (SD) Median Floor effect Ceiling effect
Symptoms 56.5 (25.1) 60.7 2 (1.7%) 5 (4.3%)
Pain 61.9 (26.0) 60.0 0 (0.0%) 9 (7.7%)
ADL 57.3 (28.4) 57.3 2 (1.7%) 7 (6.0%)
Sport* 41.6 (30.1) 41.6 6 (5.1%) 4 (3.4%)
PA 40.5 (28.2) 40.5 15 (12.8%) 9 (7.7%)
QOL 45.1 (24.4) 45.1 2 (1.7%) 3 (2.6%)
Floor and ceiling effects are reported as N (%).
* N = 116.
Abbreviations: Symptoms, symptoms in hip and/or groin; Pain, pain in hip and/or groin; ADL, function in daily living; Sport, function in sport and recreation;
PA, participation in physical activities; QOL, hip and/or groin-related quality of life.
https://doi.org/10.1371/journal.pone.0186064.t006
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be expected, but were not found. Sub-analysis with physically active and inactive patients
showed similar results, suggesting that the HAGOS-NL may also be suitable for inactive
patients. However, more research is needed to draw definite conclusions.
In conclusion, the HAGOS-NL is a reliable and valid instrument for measuring pain, physi-
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